http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c608d957d61ec725cda7b45431186331
Outgoing Links
Predicate | Object |
---|---|
family-name | Spiegelman |
name | Bruce M. Spiegelman Bruce M Spiegelman |
given-name | Bruce M Bruce M. |
organization-name | Department of Cell Biology, Dana–Farber Cancer Institute, Harvard Medical School, Boston, MA 02115; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Departments of Cancer Biology and Cell Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215, United States Department of Cell Biology, Dana–Farber Cancer Institute, Harvard Medical School, Boston, MA 02115 R. J. Distel, R. Ellis, B. M. Spiegelman, Dana Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Dana Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115; and National Cancer Institute and Laboratory of Metabolism, National Institutes of Health, Bethesda, MD 20892 Department of Cell Biology, Harvard Medical School, Boston, MA, 02215; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215 Department of Cell Biology, Harvard Medical School, Dana Farber Cancer Institute, Boston, MA 02215;; Department of Cancer Biology, Harvard Medical School, Dana Farber Cancer Institute, Boston, MA 02215; Departments of Cell Biology (J.L.E., B.M.S.), Cancer Biology, and Division of Metabolism and Chronic Disease, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215; Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Minneapolis, Minnesota 55455 Dana-Farber Cancer Institute and the Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115 Dana Farber Cancer Institute and Department of Cell Biology, Harvard Medical School Boston, Massachusetts Department of Cell Biology, Harvard Medical School; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts Dana-Farber Cancer Institute and the Department of Cell Biology, Harvard Medical School Boston, Massachusetts Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, E18-580, Cambridge, MA 02139, USA.; Division of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, E18-580, Cambridge, MA 02139, USA.; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Harvard Medical School, Boston, MA 02115, USA.; Department of Pathology, Harvard Medical School, 77 Louis Pasteur Avenue, Boston, MA 02115, USA.; Dana-Farber Cancer Institute and the Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Department of Cancer Biology, Dana–Farber Cancer Institute, Boston, MA 02115; and; Department of Cell Biology, Harvard Medical School, Boston, MA 02115 Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115;; Department of Cell Biology, Harvard Medical School, Boston, MA 02115; Dana-Farber Cancer Institute and the Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115. Dana–Farber Cancer Institute and Department of Cell Biology, Department of Pathology, Harvard Medical School, Boston, MA 02115; Human Cancer Genetics Program, Ohio State University Comprehensive Cancer Center, Columbus, OH 43210; Center for Molecular Medicine, University of Connecticut Health Center, Farmington, CT 06117; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461; Harvard Partners Center for Genetics and Genomics, Boston, MA 02115; and Laboratory of Metabolism,... Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02215; and Department of Cell Biology (B.M.S.), Harvard Medical School, and Dana-Farber Cancer Institute, Boston, Massachusetts 02115 Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115; Hematology-Oncology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; Department of Adult Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; Medicine Branch, National Cancer Institute, National ... Dana-Farber Cancer Institute, Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115 *Dana Farber Cancer Institute and the Department of Cell Biology, Harvard Medical School, Boston, MA 02115; Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115; Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115; Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115 Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 G. S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, B. M. Spiegelman, Department of Cellular and Molecular Biology, Dana-Farber Cancer Institute, and Department of Cell Biology, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA. Dana Farber Cancer Institute, Harvard Medical School, Boston, MA Dana-Farber Cancer Institute and the Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. The Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115 Department of Cancer Biology, Dana–Farber Cancer Institute, Harvard Medical School, Boston, MA 02115;; Department of Cell Biology, Harvard Medical School, Boston, MA 02115; Dana-Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115 Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, 02215, Boston, MA, USA Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Departments of Adult Oncology and Cell Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115; and Departments of Pathology and Surgery, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115 Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115; The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, and Dana–Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115; and X-Ceptor Therapeutics Inc., San Diego, CA 92121 Department of Cancer Biology, The Dana-Farber Cancer Institute, Boston, Massachusetts 02115 Dana-Farber Cancer Institute Dana-Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115. *Department of Cell Biology, Harvard Medical School, Boston, MA 02115;; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115; Dana Farber Cancer Institute, Boston, United States Department of Cell Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115 Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA. Dana-Farber Cancer Institute, Department of Cell Biology, Harvard Medical School, Boston, Massachusetts Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115 Dana–Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115; Howard Hughes Medical Institute, and Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037; and Departments of Surgery and Pathology, Brigham and Women’s Hospital, Boston, MA 02115 Dana–Farber Cancer Institute, Department of Cell Biology, and Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, MA 02115; and Center for Cardiovascular Research, Department of Medicine and Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110 Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115; and Department of Cancer Biology and Division of Metabolism and Chronic Disease, Dana-Farber Cancer Institute, Boston, Massachusetts, USA 2Dana-Farber Cancer Institute and Department of Cell Biology, Dana-Farber Cancer Institute and Harvard Medical School, Department of Immunology and Infectious Diseases, Harvard School of Public Health, 651 Huntington Avenue, Boston, MA 02115; Department of Microbiology, College of Physicians and Surgeons at Columbia University, 701 West 168th Street, New York, NY 10032; Department of Cellular and Molecular Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115; and Harvard Medical School, Boston, MA 02115 Dana-Farber Cancer Institute; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 Dana–Farber Cancer Institute and the Department of Cell Biology, Harvard Medical School, Boston, MA 02115 Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer institute and Department of Pharmacology, Harvard Medical School, Boston, MA 02115. *Dana–Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115; and Dana–Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115 Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA Department of Cancer Biology, Dana–Farber Cancer Institute, Boston, MA 02115;; Department of Cell Biology, Harvard Medical School, Boston, MA 02115; Department of Cancer Biology (R.R.R., B.M.S.), Dana-Farber Cancer Institute, Boston, Massachusetts 02215; Department of Cell Biology (R.R.R., B.M.S.), Harvard Medical School, Boston, Massachusetts 02215 Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115;; Diabetes Unit, Massachusetts General Hospital, Boston, Massachusetts 02114; Department of Cell Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115 |
Incoming Links
Total number of triples: 353.